Basic HTML Version
87
SCIENTIFIC REPORT 2012
Q1 INFECTIOUS DISEASES
Service: Critics Center
R & D & I Area: Infections, AIDS and Sepsis (Clinical and translational research)
J Clin Oncol
. 2012 Jun 10; 30 (17): 2070-8.
Sunitinib plus erlotinib versus placebo plus erlotinib in patients
with previously treated advanced non-small-cell lung cancer: a
phase III trial
.
Scagliotti GV, Krzakowski M, Szczesna A, Strausz J, Makhson A,
Reck M, Wierzbicki RF, Albert I, Thomas M, Miziara JE, Papai ZS,
Karaseva N, Thongprasert S, Dalmau Portulas ED, von Pawel J,
Zhang K, Selaru P, Tye L, Chao RC, Govindan R.
FI: 18,038
Q1 ONCOLOGY
Service: Oncology
R + D + i Area: Cancer (Clinical and translational research)
PLoS Med
. 2012; 9 (3): e1001194.
CD4 cell count and the risk of AIDS or death in HIV-Infected
adults on combination antiretroviral therapy with a suppressed
viral load: a longitudinal cohort study from COHERE
.
Opportunistic Infections Project Team of the Collaboration of
Observational HIV Epidemiological Research in Europe (COHERE) in
EuroCoord (Navarro G.), Young J, Psichogiou M, Meyer L, Ayayi S,
Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel
N, Kirk O, Miro JM, Furrer H, Castagna A, De Wit S, Muñoz J, Kjaer
J, Grarup J, Oak G, Bucher H.
FI: 15,253
Q1 MEDICINE, JANUARY
nal
Service: Epi
ology
R + D + i area
ions, AIDS and Sepsis (Clinical and Translational Research)